The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9085572, 46 ID: ALA3683785
PubChem CID: 59186986
Max Phase: Preclinical
Molecular Formula: C22H19N5O2
Molecular Weight: 385.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Cc1ccccc1)NCc1ccnc(-n2[nH]cc(-c3cccnc3)c2=O)c1
Standard InChI: InChI=1S/C22H19N5O2/c28-21(12-16-5-2-1-3-6-16)25-13-17-8-10-24-20(11-17)27-22(29)19(15-26-27)18-7-4-9-23-14-18/h1-11,14-15,26H,12-13H2,(H,25,28)
Standard InChI Key: YSIOFIYWFXTLFW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.5548 -3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1895 -7.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 -8.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7875 -7.5110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7876 -6.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 -5.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0873 -5.2606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2228 -3.7796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6896 -3.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4416 -4.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4397 -5.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6840 -7.0544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9344 -4.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8992 -3.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3754 -4.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8828 -5.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9141 -6.5989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4380 -6.3326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
2 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
22 23 2 0
21 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1539AlogP: 2.48#Rotatable Bonds: 6Polar Surface Area: 92.67Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.93CX Basic pKa: 4.45CX LogP: 1.54CX LogD: 0.64Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -1.28
References 1. (2015) 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases,